Holen Sie sich die Stockscreener-App
8.365
7.63%
-0.675
Schlusskurs vom Vortag:
$9.04
Offen:
$8.7
24-Stunden-Volumen:
2.19M
Relative Volume:
2.42
Marktkapitalisierung:
$450.91M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-86.60M
KGV:
-2.9533
EPS:
-2.8324
Netto-Cashflow:
$-67.37M
1W Leistung:
-17.16%
1M Leistung:
+26.13%
6M Leistung:
+79.96%
1J Leistung:
+1.33%
1-Tages-Spanne:
$8.14
$9.0399
1-Wochen-Bereich:
$8.14
$10.38
52-Wochen-Spanne:
$1.45
$11.72
Lexeo Therapeutics Inc Stock (LXEO) Company Profile
Firmenname
Lexeo Therapeutics Inc
Sektor
Branche
Telefon
(212) 547-9879
Adresse
345 PARK AVENUE SOUTH, NEW YORK
Vergleichen Sie LXEO mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LXEO
Lexeo Therapeutics Inc
|
8.35 | 650.61M | 0 | -86.60M | -67.37M | -2.8324 |
|
VRTX
Vertex Pharmaceuticals Inc
|
427.27 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
631.37 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
425.69 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
837.92 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
183.75 | 39.72B | 447.02M | -1.18B | -868.57M | -6.1812 |
Lexeo Therapeutics Inc Stock (LXEO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-15 | Eingeleitet | Guggenheim | Buy |
| 2025-07-31 | Eingeleitet | Oppenheimer | Outperform |
| 2024-06-13 | Eingeleitet | Robert W. Baird | Outperform |
| 2024-06-06 | Eingeleitet | H.C. Wainwright | Buy |
| 2023-11-28 | Eingeleitet | Chardan Capital Markets | Buy |
| 2023-11-28 | Eingeleitet | JP Morgan | Overweight |
| 2023-11-28 | Eingeleitet | Leerink Partners | Outperform |
| 2023-11-28 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2023-11-28 | Eingeleitet | Stifel | Buy |
Alle ansehen
Lexeo Therapeutics Inc Aktie (LXEO) Neueste Nachrichten
Using data models to predict Lexeo Therapeutics Inc. stock movementJuly 2025 Momentum & Low Drawdown Momentum Ideas - newser.com
Using Python tools to backtest Lexeo Therapeutics Inc. strategiesQuarterly Earnings Report & Weekly Watchlist for Hot Stocks - newser.com
What to do if you’re stuck in Lexeo Therapeutics Inc.Market Risk Analysis & Weekly Watchlist of Top Performers - newser.com
Long term hold vs stop loss in Lexeo Therapeutics Inc.Gap Down & AI Driven Stock Reports - newser.com
How Lexeo Therapeutics Inc. stock reacts to bond yieldsEarnings Miss & Smart Allocation Stock Reports - newser.com
Can Lexeo Therapeutics Inc. stock withstand economic slowdown2025 Top Gainers & Verified Short-Term Trading Plans - newser.com
Using Ichimoku Cloud for Lexeo Therapeutics Inc. technicalsPortfolio Value Report & Real-Time Market Trend Scan - newser.com
Multi asset correlation models including Lexeo Therapeutics Inc.July 2025 Levels & Real-Time Chart Breakout Alerts - newser.com
Is Lexeo Therapeutics (LXEO) One of Billionaire Daniel Sundheim’s Stock Picks with Huge Upside Potential - Yahoo! Finance Canada
Is Lexeo Therapeutics Inc. meeting your algorithmic filter criteriaAnalyst Upgrade & Safe Investment Capital Preservation Plans - newser.com
Will Lexeo Therapeutics Inc. price bounce be sustainableTrade Volume Summary & Verified Technical Trade Signals - newser.com
Using data filters to optimize entry into Lexeo Therapeutics Inc.Portfolio Return Summary & Verified Momentum Stock Ideas - newser.com
Will Lexeo Therapeutics Inc. stock outperform Nasdaq index2025 EndofYear Setup & Safe Capital Allocation Plans - newser.com
Should you hold or exit Lexeo Therapeutics Inc. nowWeekly Volume Report & Risk Managed Investment Strategies - newser.com
Why hedge funds are buying Lexeo Therapeutics Inc. stockEarnings Beat & High Conviction Buy Zone Picks - newser.com
Best data tools to analyze Lexeo Therapeutics Inc. stockGap Down & Weekly Return Optimization Plans - newser.com
Real time pattern detection on Lexeo Therapeutics Inc. stock2025 Growth vs Value & Fast Gain Stock Trading Tips - newser.com
Can Lexeo Therapeutics Inc. stock double in next 5 yearsJuly 2025 Opening Moves & Risk Controlled Swing Trade Alerts - newser.com
RA CAPITAL MANAGEMENT, L.P. Acquires 5 Million Shares in Lexeo T - GuruFocus
RA CAPITAL MANAGEMENT, L.P. Acquires 5 Million Shares in Lexeo Therapeutics Inc - GuruFocus
Risk vs reward if holding onto Lexeo Therapeutics Inc.Market Activity Recap & Real-Time Stock Entry Alerts - newser.com
Lexeo Therapeutics (LXEO) Price Target Increased by 19.77% to 21.29 - Nasdaq
Finanzdaten der Lexeo Therapeutics Inc-Aktie (LXEO)
Umsatz
Nettogewinn
Free Cashflow
ENV
Lexeo Therapeutics Inc-Aktie (LXEO) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Robertson Jenny | Chief Legal Officer |
Oct 17 '25 |
Sale |
8.94 |
3,526 |
31,530 |
68,930 |
| Otero Jose Manuel | Chief Technical Officer |
Oct 17 '25 |
Sale |
8.94 |
2,115 |
18,913 |
64,197 |
| Adler Eric | Chief Medical Officer |
Oct 17 '25 |
Sale |
8.94 |
3,382 |
30,242 |
73,261 |
| Townsend Richard Nolan | Chief Executive Officer |
Oct 17 '25 |
Sale |
8.94 |
13,133 |
117,436 |
242,118 |
1.02%
0.57%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):